Showing posts with label Aderans. Show all posts
Showing posts with label Aderans. Show all posts

Saturday, September 7, 2013

Cloning: The future in hair transplants

Cloning: The future in hair transplants


Date: Visited September 7th, 2013
Source:
ilterclinic.com

At the Ilter Clinic, we pay constant attention to new scientific and technical advancements in hair transplantation. We are also active in researching new progress in the field so that ever-better techniques may be developed in the future.



High-tech research is providing new hope. These methods are still far from becoming commercially available, but gene therapy and cloning may one day reduce limitations we face in the donor area.

Gene therapy

The idea behind gene therapy is to introduce new DNA into a patient’s hair cells. The new DNA would prevent cells from being affected by the DHT (dihydrotestosteron) hormone that causes Male Pattern Baldness.



However, the research is still in its infancy. Some genes have already been identified as the cause behind hair loss, but there are still many other factors to be considered. With this in mind, a great deal of research needs to be done before gene therapy becomes a reality.

Hair cloning

Cloning hair follicles is a new technology. Even though it is considered something of a Holy Grail for people suffering from hair loss because of the potential for an unlimited supply of hair from a single strand, cloning hair follicles is keenly debated. There have been exciting breakthroughs, but the method needs another ten years of research before it is commercially available.

There are two organizations seriously researching a commercially viable way to multiply hair loss-resistant donor follicles. They are Aderans, headquartered in Japan, and Intercytex, based in England.

Hair cloning is a lay term for tissue-developed hair growth. The approach being pursued involves extracting single hair cells from the hair loss-resistant donor area and attempting to replicate them in the laboratory. These "dermal papilla" cells mature into hair follicles in a process known as follicular neogenesis. If they can be stimulated to multiply, then theoretically there is no limit to the number of hair follicles that could be grown in the laboratory and transplanted onto a person’s scalp.



However, controlling the direction of new hair growth from cloned follicles has been problematic. Many people believe hair cell implants will initially be used as filler hair, primarily on the top and crown areas, while critical areas such as the hairline will continue to receive transplants using conventional FUE grafts. Also, the cost of this laboratory-intensive procedure is expected to exceed conventional hair transplantation when it is introduced.

At this point in time, it is not recommended that patients wait for cloning. If and when hair cell implants arrive in the future, they could well be used to create even greater levels of density and fullness behind the transplanted hairline.

Sunday, August 11, 2013

Aderans bankrupt?! => Aderans Research Institute Facility Closure, Marietta GA – Lab and Office Equipment Auction to be Hosted by BioSurplus

Aderans Research Institute Facility Closure, Marietta GA – Lab and Office Equipment Auction to be Hosted by BioSurplus



Online Auction To Take Place July 11–18, 2013
 
SAN DIEGO–()– BioSurplus announced today that it will host a timed, online facility closure auction of all lab equipment, furniture and disposables from the Aderans Research Institute, located in Marietta, GA, 20 minutes north of Atlanta.
 
The auction begins on July 11, and features a wide variety of lab equipment including a Zeiss confocal microscope with computer and anti-vibration table, a BioMerieux BacT/Alert 3D microbial analysis system, a Beckman Coulter Cell Lab Quanta SC flow cytometer, many newer biosafety cabinets, Sanyo incubators and refrigerators, an Olympian back up power generator, as well as general equipment such as water baths, hotplates, vacuum pumps, vortexers, lab furniture and consumables.
 
A viewing of the auction items will take place on-site on Wednesday, July 10, 2013 from 9AM to 6PM EDT at the following address:
 
2211 Newmarket Parkway, Suite 142, Marietta, GA 30067
 
Please visit http://auctions.biosurplus.com for more information and to view the online catalog, or call 858-550-0800 ext. 222.
 
 
About BioSurplus
Since 2002, BioSurplus has assembled a team of scientific experts to pioneer leading edge solutions for every stage of the lab equipment lifecycle. From providing a website of dynamic inventory, as well as online auctions, to providing service and repair, to offering turnkey solutions for selling surplus assets, BioSurplus is dedicated to maximizing the value and use of laboratory equipment for its customers. To this end, it has become a leading supplier of pre-owned laboratory instruments and equipment management services.

BioSurplus is headquartered in San Diego and has lab equipment megastores in San Diego, the San Francisco Bay Area, Boston and Korea. BioSurplus offers services nationally and sells equipment worldwide. For more information, please visit the corporate website at www.biosurplus.com. Keep up with the latest news on the BioSurplus blog.

Thursday, March 14, 2013

Aderans Research – advancing hair regeneration™

Aderans Research – advancing hair regeneration™


Source: aderansresearch.com

 Aderans Research Institute (ARI)
A Cell-Based Alternative
Aderans Research Institute (ARI) is a leading commercial force in the field of hair regeneration, pioneering innovative cell-based solutions to the problems of pattern hair loss that affect millions of people around the world. Historically, hair transplantation has been limited by the number of available hairs on the head in question, but cellular regeneration may make it possible to multiply hairs, providing a potentially unlimited supply of hair growth for up to 80 million Americans suffering from pattern hair loss. With rejuvenated hair follicles producing healthy hair, people can get back to the business of leading confident, productive lives.

We invite anyone facing the challenge of hair loss to consider participating in our clinical study clinical study.

 

Hailed as a breakthrough in the science of hair loss, cellular hair regeneration is a cutting-edge technique that promises to address the riddle of the finite number of hair follicles. In the past, hair loss treatments, including surgical transplantation or medication, faced a troublesome problem: the finite number of hairs on an individual's head limited the degree of redistribution possible. Once a person begins to lose hair, his or her supply of hair-generating follicles necessarily diminishes. For clients who are considerably bald, there often isn't enough hair on the back of the head to make up for the loss on top, leaving the client with a make-do patchwork of thinly implanted follicles.



Cellular hair regeneration offers a remarkable solution to the problem. By encouraging follicular cells to reproduce themselves via a method ARI calls the Ji Gami™ process, practically an unlimited number of hair-generating cellular units can be produced. During this process, often called hair multiplication or hair cloning, a small piece of tissue is removed from the neckline. Cells are cultivated in controlled conditions where they are encouraged to multiply by the addition of proprietary growth media. When enough new cells are formed, they are returned to the scalp, where they are injected and elicit new hair growth and thickness, ultimately producing more hair than the client had before. Candidates for hair regeneration may no longer be limited by the number of hairs on their head. ARI envisions a time when crowns (vertex) can be covered with full, natural hair regardless of the degree of hair loss.



It should be noted that ARI treatments are entirely autologous. That means ARI only attempts to generate hair growth using the participant's own hair. No foreign growth media, such as plant- or animal-derived growth factors, are involved. When the cultivated hair cells are restored to the participant's scalp, he or she is only receiving his or her hair cells. This serum–free process delivers a degree of safety from complications unique to the field.

Please view the short video that explains the procedure in detail: